195 related articles for article (PubMed ID: 19227610)
1. [The role of hydromorphone in pain killing].
Telekes A
Lege Artis Med; 2008 Oct; 18(10):675-9. PubMed ID: 19227610
[TBL] [Abstract][Full Text] [Related]
2. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
Coluzzi F; Mattia C
Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
[TBL] [Abstract][Full Text] [Related]
3. Oral hydromorphone extended-release.
Guay DR
Consult Pharm; 2010 Dec; 25(12):816-28. PubMed ID: 21172762
[TBL] [Abstract][Full Text] [Related]
4. Hydromorphone: evolving to meet the challenges of today's health care environment.
Gregory TB
Clin Ther; 2013 Dec; 35(12):2007-27. PubMed ID: 24290733
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
6. [New opioid preparations in the treatment of pain].
Kalso E
Duodecim; 1999; 115(20):2211-4. PubMed ID: 11973924
[No Abstract] [Full Text] [Related]
7. [Pharmacotherapy of chronic, non-tumour related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone].
Sabatowski R; Giesecke T
MMW Fortschr Med; 2007 Sep; 149 Suppl 3():119-24. PubMed ID: 17955789
[TBL] [Abstract][Full Text] [Related]
8. Hydromorphone: pharmacology and clinical applications in cancer patients.
Sarhill N; Walsh D; Nelson KA
Support Care Cancer; 2001 Mar; 9(2):84-96. PubMed ID: 11305075
[TBL] [Abstract][Full Text] [Related]
9. Hydromorphone.
Pasero C; McCaffery M
Am J Nurs; 2001 Feb; 101(2):22-3. PubMed ID: 11227223
[No Abstract] [Full Text] [Related]
10. [Pain therapy with semisynthetic opioids. Patients have opioid-type side effects more rarely].
Sohn W
MMW Fortschr Med; 2003 Jul; 145(27-28):50. PubMed ID: 14587190
[No Abstract] [Full Text] [Related]
11. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
12. Hydromorphone-OROS formulation.
Goforth HW
Expert Opin Pharmacother; 2010 May; 11(7):1207-14. PubMed ID: 20402557
[TBL] [Abstract][Full Text] [Related]
13. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
Guedes AG; Papich MG; Rude EP; Rider MA
J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effects of epidural administration of hydromorphone in horses.
Natalini CC; Linardi RL
Am J Vet Res; 2006 Jan; 67(1):11-5. PubMed ID: 16426205
[TBL] [Abstract][Full Text] [Related]
16. Hydromorphone.
Murray A; Hagen NA
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S57-66. PubMed ID: 15907647
[TBL] [Abstract][Full Text] [Related]
17. The metamorphosis of hydromorphone.
Reisfield GM; Wilson GR
J Opioid Manag; 2005; 1(3):139-45. PubMed ID: 17315417
[TBL] [Abstract][Full Text] [Related]
18. [Hydromorphone--review of pharmacological properties and therapeutic efficacy with special regard to a controlled release preparation].
Lindena G; Arnau H; Liefhold J
Schmerz; 1998 Jul; 12(3):195-204. PubMed ID: 12799972
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of orally administered sustained- release hydromorphone in humans.
Angst MS; Drover DR; Lötsch J; Ramaswamy B; Naidu S; Wada DR; Stanski DR
Anesthesiology; 2001 Jan; 94(1):63-73. PubMed ID: 11135723
[TBL] [Abstract][Full Text] [Related]
20. Exceptionally high narcotic analgesic requirements in a terminally ill cancer patient.
Lo SL; Coleman RR
Clin Pharm; 1986 Oct; 5(10):828-32. PubMed ID: 2430752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
